# pathway_nodes

date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
labels: INFLIXIMAB
cost_pp_pa: 3892.1
first_seen: 2024-02-08T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-08
last_seen_parent: 2025-12-30
average_administered: [6.782178217821782, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6.8 times with a 5.0 weekly interval (34.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
labels: VEDOLIZUMAB
cost_pp_pa: 16995.8
first_seen: 2024-02-14T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-14
last_seen_parent: 2025-12-31
average_administered: [6.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 6.8 times with a 5.4 weekly interval (37.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4755.87
first_seen: 2024-02-26T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-23
average_administered: [4.6380952380952385, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.6 times with a 6.6 weekly interval (30.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 1878.09
first_seen: 2024-02-29T00:00:00
last_seen: 2025-10-07T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-31
average_administered: [4.098684210526316, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.1 times with a 7.0 weekly interval (29.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma
labels: RITUXIMAB
cost_pp_pa: 5488.71
first_seen: 2024-04-08T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-08
last_seen_parent: 2025-12-31
average_administered: [11.874125874125873, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: follicular lymphoma
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11.9 times with a 2.4 weekly interval (29.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - giant cell arteritis
labels: TOCILIZUMAB
cost_pp_pa: 11949.76
first_seen: 2024-04-12T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-12
last_seen_parent: 2025-12-29
average_administered: [7.842105263157895, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: giant cell arteritis
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 7.8 times with a 4.1 weekly interval (32.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: FILGOTINIB
cost_pp_pa: 2258.09
first_seen: 2024-02-13T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2024-02-13
last_seen_parent: 2025-12-22
average_administered: [4.625, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: FILGOTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FILGOTINIB</b><br>On average given 4.6 times with a 7.0 weekly interval (32.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: RITUXIMAB
cost_pp_pa: 3376.61
first_seen: 2024-02-23T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-31
average_administered: [3.7777777777777777, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 3.8 times with a 6.9 weekly interval (26.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
labels: ADALIMUMAB
cost_pp_pa: 1766.1
first_seen: 2024-02-13T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-13
last_seen_parent: 2025-12-30
average_administered: [8.454545454545455, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.5 times with a 7.7 weekly interval (66.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
labels: UPADACITINIB
cost_pp_pa: 6075.99
first_seen: 2024-10-11T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2024-03-19
last_seen_parent: 2025-12-16
average_administered: [4.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - UPADACITINIB

average_spacing:
<br><b>UPADACITINIB</b><br>On average given 4.6 times with a 5.0 weekly interval (23.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - retinal vein occlusion
labels: DEXAMETHASONE
cost_pp_pa: 3306.0
first_seen: 2024-02-12T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-12-15
average_administered: [2.375, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: retinal vein occlusion
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 2.4 times with a 29.1 weekly interval (70.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
labels: ALIROCUMAB
cost_pp_pa: 2397.79
first_seen: 2024-02-13T00:00:00
last_seen: 2025-12-09T00:00:00
first_seen_parent: 2024-02-13
last_seen_parent: 2025-12-09
average_administered: [9.3, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CHEMICAL PATHOLOGY (no GP dx)
drug_sequence: ALIROCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ALIROCUMAB</b><br>On average given 9.3 times with a 6.9 weekly interval (64.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer
labels: BEVACIZUMAB
cost_pp_pa: 1648.52
first_seen: 2024-03-28T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2024-03-28
last_seen_parent: 2025-12-19
average_administered: [5.333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ovarian cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5.3 times with a 5.7 weekly interval (30.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: ADALIMUMAB
cost_pp_pa: 1920.4
first_seen: 2024-02-13T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-13
last_seen_parent: 2025-12-29
average_administered: [8.385964912280702, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.4 times with a 8.0 weekly interval (67.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 10969.8
first_seen: 2024-04-02T00:00:00
last_seen: 2025-11-04T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-11-04
average_administered: [4.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 4.2 times with a 13.3 weekly interval (56.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3878.27
first_seen: 2024-05-15T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-05-15
last_seen_parent: 2025-12-30
average_administered: [5.739130434782608, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.7 times with a 7.1 weekly interval (41.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 1359.34
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-30
average_administered: [4.7967914438502675, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.8 times with a 8.6 weekly interval (41.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 2883.84
first_seen: 2024-02-12T00:00:00
last_seen: 2025-09-25T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-09-25
average_administered: [4.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: migraine
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 4.2 times with a 17.9 weekly interval (75.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 2896.78
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-30
average_administered: [10.071428571428571, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ovarian cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 10.1 times with a 2.6 weekly interval (26.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1675.01
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-29
average_administered: [6.26530612244898, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.3 times with a 9.9 weekly interval (62.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 5149.16
first_seen: 2024-02-23T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-31
average_administered: [1.8181818181818181, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 1.8 times with a 11.9 weekly interval (21.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 5386.8
first_seen: 2024-04-21T00:00:00
last_seen: 2025-12-26T00:00:00
first_seen_parent: 2024-04-21
last_seen_parent: 2025-12-26
average_administered: [5.310344827586207, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.3 times with a 5.6 weekly interval (30.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 1794.76
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-30
average_administered: [4.504065040650406, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.5 times with a 9.0 weekly interval (40.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - hepatocellular carcinoma
labels: ATEZOLIZUMAB
cost_pp_pa: 21316.05
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-30
average_administered: [10.507936507936508, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: hepatocellular carcinoma
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 10.5 times with a 3.3 weekly interval (34.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
labels: UPADACITINIB
cost_pp_pa: 9248.97
first_seen: 2024-03-05T00:00:00
last_seen: 2025-12-12T00:00:00
first_seen_parent: 2024-03-05
last_seen_parent: 2025-12-12
average_administered: [6.111111111111111, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>UPADACITINIB</b><br>On average given 6.1 times with a 7.4 weekly interval (45.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - uveitis
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1674.99
first_seen: 2024-03-25T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-03-25
last_seen_parent: 2025-12-30
average_administered: [8.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: uveitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.0 times with a 9.1 weekly interval (73.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2405.48
first_seen: 2024-02-21T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-21
last_seen_parent: 2025-12-31
average_administered: [6.536585365853658, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.5 times with a 9.0 weekly interval (58.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 7908.32
first_seen: 2024-02-23T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-31
average_administered: [7.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7.2 times with a 4.7 weekly interval (34.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4578.66
first_seen: 2024-06-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-06-04
last_seen_parent: 2025-12-30
average_administered: [5.714285714285714, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 5.7 times with a 10.7 weekly interval (61.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - axial spondyloarthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - axial spondyloarthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2705.62
first_seen: 2024-02-08T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2024-02-08
last_seen_parent: 2025-12-19
average_administered: [4.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.4 times with a 9.6 weekly interval (42.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 5709.89
first_seen: 2024-06-10T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2024-05-20
last_seen_parent: 2025-12-22
average_administered: [5.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5.0 times with a 7.0 weekly interval (35.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1692.8
first_seen: 2024-02-21T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-21
last_seen_parent: 2025-12-31
average_administered: [5.326530612244898, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.3 times with a 10.1 weekly interval (54.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4510.98
first_seen: 2024-06-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-06-06
last_seen_parent: 2025-12-31
average_administered: [6.391304347826087, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 6.4 times with a 11.7 weekly interval (75.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3903.62
first_seen: 2024-05-05T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-05-05
last_seen_parent: 2025-12-30
average_administered: [5.857142857142857, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5.9 times with a 5.1 weekly interval (30.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3269.98
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-29
average_administered: [5.790123456790123, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 5.8 times with a 9.0 weekly interval (52.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 444.95
first_seen: 2024-04-19T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2024-04-19
last_seen_parent: 2025-12-08
average_administered: [2.142857142857143, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 2.1 times with a 7.0 weekly interval (15.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - colorectal cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 853.38
first_seen: 2024-02-28T00:00:00
last_seen: 2025-12-27T00:00:00
first_seen_parent: 2024-02-28
last_seen_parent: 2025-12-27
average_administered: [6.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: colorectal cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 6.0 times with a 6.0 weekly interval (36.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3957.56
first_seen: 2024-02-14T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-14
last_seen_parent: 2025-12-31
average_administered: [6.326530612244898, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6.3 times with a 5.3 weekly interval (33.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 6050.0
first_seen: 2024-03-20T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-03-20
last_seen_parent: 2025-12-30
average_administered: [5.6571428571428575, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5.7 times with a 4.6 weekly interval (26.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 17406.38
first_seen: 2024-03-01T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-03-01
last_seen_parent: 2025-12-31
average_administered: [8.181818181818182, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: crohn's disease
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 8.2 times with a 5.1 weekly interval (42.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4041.69
first_seen: 2024-03-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-03-06
last_seen_parent: 2025-12-31
average_administered: [5.953488372093023, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 6.0 times with a 7.6 weekly interval (45.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - atopic dermatitis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - atopic dermatitis - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 8035.96
first_seen: 2024-04-05T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-04-05
last_seen_parent: 2025-12-24
average_administered: [6.333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: atopic dermatitis
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 6.3 times with a 8.6 weekly interval (54.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis
labels: ADALIMUMAB
cost_pp_pa: 1072.87
first_seen: 2024-06-06T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2024-06-06
last_seen_parent: 2025-11-26
average_administered: [3.111111111111111, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.1 times with a 13.3 weekly interval (41.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 438.37
first_seen: 2024-04-14T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-14
last_seen_parent: 2025-12-30
average_administered: [4.384615384615385, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: breast cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 4.4 times with a 5.3 weekly interval (23.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia
labels: RITUXIMAB
cost_pp_pa: 3917.59
first_seen: 2024-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-12-31
average_administered: [11.368421052631579, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: chronic lymphocytic leukaemia
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11.4 times with a 2.4 weekly interval (28.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: INFLIXIMAB
cost_pp_pa: 1911.66
first_seen: 2024-08-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-08-06
last_seen_parent: 2025-12-31
average_administered: [5.833333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5.8 times with a 4.6 weekly interval (27.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: RITUXIMAB
cost_pp_pa: 1607.47
first_seen: 2024-04-08T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-08
last_seen_parent: 2025-12-30
average_administered: [5.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5.2 times with a 9.0 weekly interval (47.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4614.36
first_seen: 2024-02-29T00:00:00
last_seen: 2025-12-03T00:00:00
first_seen_parent: 2024-02-29
last_seen_parent: 2025-12-03
average_administered: [6.909090909090909, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 6.9 times with a 6.9 weekly interval (47.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 8795.34
first_seen: 2024-04-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-12-29
average_administered: [5.631578947368421, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: asthma
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 5.6 times with a 7.7 weekly interval (43.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: RANIBIZUMAB
cost_pp_pa: 1849.42
first_seen: 2024-08-27T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-06-24
last_seen_parent: 2025-12-30
average_administered: [3.740740740740741, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.7 times with a 5.7 weekly interval (21.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1917.88
first_seen: 2024-02-29T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-29
last_seen_parent: 2025-12-31
average_administered: [4.816901408450704, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.8 times with a 10.3 weekly interval (49.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2670.59
first_seen: 2024-04-16T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-16
last_seen_parent: 2025-12-29
average_administered: [5.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5.0 times with a 7.4 weekly interval (37.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3071.1
first_seen: 2024-04-11T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-11
last_seen_parent: 2025-12-29
average_administered: [6.076923076923077, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.1 times with a 8.6 weekly interval (52.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3957.2
first_seen: 2024-02-12T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-12-31
average_administered: [5.623529411764705, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.6 times with a 6.1 weekly interval (34.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2268.15
first_seen: 2024-02-16T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-15
last_seen_parent: 2025-12-29
average_administered: [5.9298245614035086, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.9 times with a 9.3 weekly interval (55.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4591.17
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-31
average_administered: [5.370786516853933, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.4 times with a 5.4 weekly interval (29.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3452.93
first_seen: 2024-02-14T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-09
last_seen_parent: 2025-12-31
average_administered: [6.513513513513513, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 6.5 times with a 8.7 weekly interval (57.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - diabetes
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - diabetes - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 5197.13
first_seen: 2024-04-03T00:00:00
last_seen: 2025-12-05T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-05
average_administered: [4.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 4.6 times with a 7.6 weekly interval (35.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3135.51
first_seen: 2024-03-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-03-04
last_seen_parent: 2025-12-31
average_administered: [3.7142857142857144, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 3.7 times with a 10.3 weekly interval (38.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - crohn's disease
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3554.69
first_seen: 2024-04-03T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-29
average_administered: [5.428571428571429, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5.4 times with a 4.0 weekly interval (22.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1591.8
first_seen: 2024-02-22T00:00:00
last_seen: 2025-11-13T00:00:00
first_seen_parent: 2024-02-22
last_seen_parent: 2025-11-13
average_administered: [3.857142857142857, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.9 times with a 4.1 weekly interval (16.0 weeks total treatment length)


